Disease | morbid obesity |
Phenotype | C0011849|diabetes mellitus |
Sentences | 7 |
PubMedID- 24729807 | Introduction: the roux-en-y gastric bypass (rygb) is an effective treatment of morbid obesity leading to type 2 diabetes mellitus (t2dm) resolution. |
PubMedID- 19733515 | morbid obesity associated with type 2 diabetes mellitus has many health implications. |
PubMedID- 23604584 | In china, morbid obesity is strongly associated with type 2 diabetes mellitus (t2dm), which has become a serious problem in modern chinese society [2]. |
PubMedID- 23198247 | Laparoscopic roux-en-y gastric bypass (lrygb) has been shown to be an effective treatment for type 2 diabetes mellitus (t2dm) in patients with morbid obesity. |
PubMedID- 22651976 | morbid obesity is usually associated with hypertension, diabetes mellitus, dermatological complications like acanthosis nigricans, skin tags, leg ulcers, edema, lymphoedema, plantar hyperkeratosis and massive localized lymphoedema (mll) is one of the complications of morbid obesity. |
PubMedID- 25470646 | Usefulness of the neutrophil-to-lymphocyte ratio to prediction of type 2 diabetes mellitus in morbid obesity. |
PubMedID- 23610825 | [surgical treatment of diabetes mellitus type ii associated with morbid obesity]. |
Page: 1